Outcomes were evaluated among children born between April 1980 and June 2019 by using data from 12 observational birth ...

Early results from the phase 1 SANRECO trial suggest that divesiran is safe and well tolerated, and may reduce the need for phlebotomy in patients with polycythemia vera by increasing hepcidin levels ...